Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Nagata, T; Hara, K; Oka, T; Yamauchi, Y; Igarashi, K; Hazama, H; Omata, M
   Microscopic polyangiitis associated with sinobronchial syndrome
   INTERNAL MEDICINE
   
   T. Nagata et al., "Microscopic polyangiitis associated with sinobronchial syndrome", INTERN MED, 40(6), 2001, pp. 544-547
2. Russell, KA; Specks, U
   Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon
   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
   
   K.A. Russell e U. Specks, "Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon", RHEUM DIS C, 27(4), 2001, pp. 815
3. Brons, RH; Kallenberg, CGM; Tervaert, JWC
   Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?
   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
   
   R.H. Brons et al., "Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?", RHEUM DIS C, 27(4), 2001, pp. 833
4. Merkel, PA
   Drug-induced vasculitis
   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
   
   P.A. Merkel, "Drug-induced vasculitis", RHEUM DIS C, 27(4), 2001, pp. 849
5. Flores-Suarez, LF; Gonzalez-Michaca, L; Jimenez, VH; Gamba, G; Simon, A; Rull, M
   ANCAS: one, two or three Fates?
   REVISTA DE INVESTIGACION CLINICA
   
   L.F. Flores-Suarez et al., "ANCAS: one, two or three Fates?", REV INV CLI, 53(2), 2001, pp. 159-173
6. Hewins, P; Tervaert, JWC; Savage, COS; Kallenberg, CGM
   Is Wegener's granulomatosis an autoimmune disease?
   CURRENT OPINION IN RHEUMATOLOGY
   
   P. Hewins et al., "Is Wegener's granulomatosis an autoimmune disease?", CURR OP RH, 12(1), 2000, pp. 3-10
7. Fujii, A; Tomizawa, K; Arimura, Y; Nagasawa, T; Ohashi, YY; Hiyama, T; Mizuno, S; Suzuki, K
   Epitope analysis of myeloperoxidase(MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis
   CLINICAL NEPHROLOGY
   
   A. Fujii et al., "Epitope analysis of myeloperoxidase(MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis", CLIN NEPHR, 53(4), 2000, pp. 242-252
8. Maes, B; Van Mieghem, A; Messiaen, T; Kuypers, D; Van Damme, B; Vanrenterghem, Y
   Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type
   AMERICAN JOURNAL OF KIDNEY DISEASES
   
   B. Maes et al., "Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type", AM J KIDNEY, 36(3), 2000, pp. NIL_49-NIL_53
9. Ara, JM; Picazo, ML; Torre, A; Pascual, D; Rodriguez, CD; Rinon, C
   Systemic sclerosis with MPO-ANCA associated vasculitis with renal and skininvolvement
   NEFROLOGIA
   
   J.M. Ara et al., "Systemic sclerosis with MPO-ANCA associated vasculitis with renal and skininvolvement", NEFROLOGIA, 20(4), 2000, pp. 383-386
10. Radford, DJ; Savage, COS; Nash, GB
    Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion
    ARTHRITIS AND RHEUMATISM
    
    D.J. Radford et al., "Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion", ARTH RHEUM, 43(6), 2000, pp. 1337-1345
11. Choi, HK; Slot, MC; Pan, GL; Weissbach, CA; Niles, JL; Merkel, PA
    Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine
    ARTHRITIS AND RHEUMATISM
    
    H.K. Choi et al., "Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine", ARTH RHEUM, 43(11), 2000, pp. 2488-2492
12. Franssen, CFM; Huitema, MG; Kobold, ACM; Oost-Kort, WW; Limburg, PC; Tiebosch, A; Stegeman, CA; Kallenberg, CGM; Tervaert, JWC
    In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    C.F.M. Franssen et al., "In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis", J AM S NEPH, 10(7), 1999, pp. 1506-1515
13. Kobold, ACM; van der Geld, YM; Limburg, PC; Tervaert, JWC; Kallenberg, GGM
    Pathophysiology of ANCA-associated glomerulonephritis
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    A.C.M. Kobold et al., "Pathophysiology of ANCA-associated glomerulonephritis", NEPH DIAL T, 14(6), 1999, pp. 1366-1375
14. Kyndt, X; Ducq, P; Bridoux, F; Reumaux, D; Makdassi, R; Gheerbrant, JD; Vanhille, P
    Extracapillary glomerulonephritis with anti-myeloperoxidase antibodies
    PRESSE MEDICALE
    
    X. Kyndt et al., "Extracapillary glomerulonephritis with anti-myeloperoxidase antibodies", PRESSE MED, 28(2), 1999, pp. 67-70
15. Nachman, PH; Segelmark, M; Westman, K; Hogan, SL; Satterly, KK; Jennette, JC; Falk, R
    Recurrent ANCA-associated small vessel vasculitis after transplantation: Apooled analysis
    KIDNEY INTERNATIONAL
    
    P.H. Nachman et al., "Recurrent ANCA-associated small vessel vasculitis after transplantation: Apooled analysis", KIDNEY INT, 56(4), 1999, pp. 1544-1550
16. Dhillon, SS; Singh, D; Doe, N; Qadri, AM; Ricciardi, S; Schwarz, MI
    Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil
    CHEST
    
    S.S. Dhillon et al., "Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil", CHEST, 116(5), 1999, pp. 1485-1488
17. Vittecoq, O; Brard, F; Jovelin, F; Le Loet, X; Tron, F; Gilbert, D
    IgM anti-myeloperoxidase antibody-secreting lymphocytes are present in theperipheral repertoire of lupus mice but rarely differentiate into IgG-producing cells
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    O. Vittecoq et al., "IgM anti-myeloperoxidase antibody-secreting lymphocytes are present in theperipheral repertoire of lupus mice but rarely differentiate into IgG-producing cells", CLIN EXP IM, 118(1), 1999, pp. 122-130
18. Radford, DJ; Lord, JM; Savage, COS
    The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    D.J. Radford et al., "The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation", CLIN EXP IM, 118(1), 1999, pp. 171-179
19. Tse, WY; Abadeh, S; McTiernan, A; Jefferis, R; Savage, COS; Adu, D
    No association between neutrophil Fc gamma RIIa allelic polymorphism and antineutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    W.Y. Tse et al., "No association between neutrophil Fc gamma RIIa allelic polymorphism and antineutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis", CLIN EXP IM, 117(1), 1999, pp. 198-205
20. Locke, IC; Leaker, B; Cambridge, G
    A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    I.C. Locke et al., "A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions", CLIN EXP IM, 115(2), 1999, pp. 369-376
21. KALLENBERG CGM; HEERINGA P
    PATHOGENESIS OF VASCULITIS
    Lupus
    
    C.G.M. Kallenberg e P. Heeringa, "PATHOGENESIS OF VASCULITIS", Lupus, 7(4), 1998, pp. 280-284
22. JENNETTE JC; FALK RJ
    PATHOGENESIS OF THE VASCULAR AND GLOMERULAR DAMAGE IN ANCA-POSITIVE VASCULITIS
    Nephrology, dialysis, transplantation
    
    J.C. Jennette e R.J. Falk, "PATHOGENESIS OF THE VASCULAR AND GLOMERULAR DAMAGE IN ANCA-POSITIVE VASCULITIS", Nephrology, dialysis, transplantation, 13, 1998, pp. 16-20
23. Homer, RJ
    Antineutrophil cytoplasmic antibodies as markers for systemic autoimmune disease
    CLINICS IN CHEST MEDICINE
    
    R.J. Homer, "Antineutrophil cytoplasmic antibodies as markers for systemic autoimmune disease", CLIN CHEST, 19(4), 1998, pp. 627
24. TOMIZAWA K; MINE E; FUJII A; OHASHI YY; YAMAGOE S; HASHIMOTO Y; ISHIDAOKAWARA A; ITO M; TANOKURA M; YAMAMOTO T; ARIMURA Y; NAGASAWA T; MIZUNO S; SUZUKI K
    A PANEL SET FOR EPITOPE ANALYSIS OF MYELOPEROXIDASE (MPO)-SPECIFIC ANTINEUTROPHIL CYTOPLASMIC ANTIBODY MPO-ANCA USING RECOMBINANT HEXAMER HISTIDINE-TAGGED MPO DELETION MUTANTS
    Journal of clinical immunology
    
    K. Tomizawa et al., "A PANEL SET FOR EPITOPE ANALYSIS OF MYELOPEROXIDASE (MPO)-SPECIFIC ANTINEUTROPHIL CYTOPLASMIC ANTIBODY MPO-ANCA USING RECOMBINANT HEXAMER HISTIDINE-TAGGED MPO DELETION MUTANTS", Journal of clinical immunology, 18(2), 1998, pp. 142-152
25. MIRAPEIX E
    PATHOGENESIS OF SMALL VESSELS VASCULITIS - CONTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES (ANCA)
    Nefrologia
    
    E. Mirapeix, "PATHOGENESIS OF SMALL VESSELS VASCULITIS - CONTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES (ANCA)", Nefrologia, 18(1), 1998, pp. 22-31
26. HEERINGA P; BROUWER E; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
    ANIMAL-MODELS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS
    Kidney international
    
    P. Heeringa et al., "ANIMAL-MODELS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS", Kidney international, 53(2), 1998, pp. 253-263
27. SUN J; FASS DN; VISS MA; HUMMEL AM; TANG H; HOMBURGER HA; SPECKS U
    A PROPORTION OF PROTEINASE-3 (PR3)-SPECIFIC ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) ONLY REACT WITH PR3 AFTER CLEAVAGE OF ITS N-TERMINAL ACTIVATION DIPEPTIDE
    Clinical and experimental immunology
    
    J. Sun et al., "A PROPORTION OF PROTEINASE-3 (PR3)-SPECIFIC ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) ONLY REACT WITH PR3 AFTER CLEAVAGE OF ITS N-TERMINAL ACTIVATION DIPEPTIDE", Clinical and experimental immunology, 114(2), 1998, pp. 320-326
28. FALK RJ; YANG JJ; JENNETTE JC
    ARE ANCA PATHOGENETIC - PROS AND CONS
    Nephrology
    
    R.J. Falk et al., "ARE ANCA PATHOGENETIC - PROS AND CONS", Nephrology, 3(6), 1997, pp. 780-782
29. LOCKE IC; WORRALL JG; LEAKER B; BLACK CM; CAMBRIDGE G
    AUTOANTIBODIES TO MYELOPEROXIDASE IN SYSTEMIC-SCLEROSIS
    Journal of rheumatology
    
    I.C. Locke et al., "AUTOANTIBODIES TO MYELOPEROXIDASE IN SYSTEMIC-SCLEROSIS", Journal of rheumatology, 24(1), 1997, pp. 86-89
30. HILLIS GS; KHAN IH; SIMPSON JG; REES AJ
    SCLERODERMA, D-PENICILLAMINE TREATMENT, AND PROGRESSIVE RENAL-FAILUREASSOCIATED WITH POSITIVE ANTIMYELOPEROXIDASE ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES
    American journal of kidney diseases
    
    G.S. Hillis et al., "SCLERODERMA, D-PENICILLAMINE TREATMENT, AND PROGRESSIVE RENAL-FAILUREASSOCIATED WITH POSITIVE ANTIMYELOPEROXIDASE ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES", American journal of kidney diseases, 30(2), 1997, pp. 279-281
31. SUTCLIFFE N; MORRIS V; GOMPERTS B; BRAZIER DJ; ISENBERG DA; CAMBRIDGE G
    RELATIONSHIP BETWEEN THE DEVELOPMENT OF BLINDNESS IN CHURG-STRAUSS-SYNDROME AND ANTIMYELOPEROXIDASE ANTIBODIES
    British journal of rheumatology
    
    N. Sutcliffe et al., "RELATIONSHIP BETWEEN THE DEVELOPMENT OF BLINDNESS IN CHURG-STRAUSS-SYNDROME AND ANTIMYELOPEROXIDASE ANTIBODIES", British journal of rheumatology, 36(2), 1997, pp. 273-275
32. KARPINSKI J; JOTHY S; RADOUX V; LEVY M; BARAN D
    D-PENICILLAMINE-INDUCED CRESCENTIC GLOMERULONEPHRITIS AND ANTIMYELOPEROXIDASE ANTIBODIES IN A PATIENT WITH SCLERODERMA - CASE-REPORT AND REVIEW OF THE LITERATURE
    American journal of nephrology
    
    J. Karpinski et al., "D-PENICILLAMINE-INDUCED CRESCENTIC GLOMERULONEPHRITIS AND ANTIMYELOPEROXIDASE ANTIBODIES IN A PATIENT WITH SCLERODERMA - CASE-REPORT AND REVIEW OF THE LITERATURE", American journal of nephrology, 17(6), 1997, pp. 528-532
33. HEERINGA P; FOUCHER P; KLOK PA; HUITEMA MG; TERVAERT JWC; WEENING JJ; KALLENBERG CGM
    SYSTEMIC INJECTION OF PRODUCTS OF ACTIVATED NEUTROPHILS AND H2O2 IN MYELOPEROXIDASE-IMMUNIZED RATS LEADS TO NECROTIZING VASCULITIS IN THE LUNGS AND GUT
    The American journal of pathology
    
    P. Heeringa et al., "SYSTEMIC INJECTION OF PRODUCTS OF ACTIVATED NEUTROPHILS AND H2O2 IN MYELOPEROXIDASE-IMMUNIZED RATS LEADS TO NECROTIZING VASCULITIS IN THE LUNGS AND GUT", The American journal of pathology, 151(1), 1997, pp. 131-140
34. TERVAERT JWC; STEGEMAN CA; KALLENBERG CGM
    SERIAL ANCA TESTING IS USEFUL IN MONITORING DISEASE-ACTIVITY OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIDES
    Sarcoidosis vasculitis and diffuse lung diseases
    
    J.W.C. Tervaert et al., "SERIAL ANCA TESTING IS USEFUL IN MONITORING DISEASE-ACTIVITY OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIDES", Sarcoidosis vasculitis and diffuse lung diseases, 13(3), 1996, pp. 241-245
35. TERVAERT JWC
    THE VALUE OF SERIAL ANCA TESTING DURING FOLLOW-UP-STUDIES IN PATIENTSWITH ANCA-ASSOCIATED VASCULITIDES - A REVIEW
    JN. Journal of nephrology
    
    J.W.C. Tervaert, "THE VALUE OF SERIAL ANCA TESTING DURING FOLLOW-UP-STUDIES IN PATIENTSWITH ANCA-ASSOCIATED VASCULITIDES - A REVIEW", JN. Journal of nephrology, 9(5), 1996, pp. 232-240
36. LOCKE IC; CAMBRIDGE G
    AUTOANTIBODIES TO NEUTROPHIL GRANULE PROTEINS - PATHOGENIC POTENTIAL IN VASCULITIS
    British journal of biomedical science
    
    I.C. Locke e G. Cambridge, "AUTOANTIBODIES TO NEUTROPHIL GRANULE PROTEINS - PATHOGENIC POTENTIAL IN VASCULITIS", British journal of biomedical science, 53(4), 1996, pp. 302-316
37. WALDHAUSER L; UETRECHT J
    ANTIBODIES TO MYELOPEROXIDASE IN PROPYLTHIOURACIL-INDUCED AUTOIMMUNE-DISEASE IN THE CAT
    Toxicology
    
    L. Waldhauser e J. Uetrecht, "ANTIBODIES TO MYELOPEROXIDASE IN PROPYLTHIOURACIL-INDUCED AUTOIMMUNE-DISEASE IN THE CAT", Toxicology, 114(2), 1996, pp. 155-162
38. FRASCA GM; NERI L; MARTELLO M; SESTIGIANI E; BORGNINO LC; BONOMINI V
    RENAL-TRANSPLANTATION IN PATIENTS WITH MICROSCOPIC POLYARTERITIS AND ANTIMYELOPEROXIDASE ANTIBODIES - REPORT OF 3 CASES
    Nephron
    
    G.M. Frasca et al., "RENAL-TRANSPLANTATION IN PATIENTS WITH MICROSCOPIC POLYARTERITIS AND ANTIMYELOPEROXIDASE ANTIBODIES - REPORT OF 3 CASES", Nephron, 72(1), 1996, pp. 82-85
39. GILLIGAN HM; BREDY B; BRADY HR; HEBERT MJ; SLAYTER HS; XU YH; RAUCH J; SHIA MA; KOH JS; LEVINE JS
    ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES INTERACT WITH PRIMARY GRANULE CONSTITUENTS ON THE SURFACE OF APOPTOTIC NEUTROPHILS IN THE ABSENCEOF NEUTROPHIL PRIMING
    The Journal of experimental medicine
    
    H.M. Gilligan et al., "ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES INTERACT WITH PRIMARY GRANULE CONSTITUENTS ON THE SURFACE OF APOPTOTIC NEUTROPHILS IN THE ABSENCEOF NEUTROPHIL PRIMING", The Journal of experimental medicine, 184(6), 1996, pp. 2231-2241
40. BROOKS CJ; KING WJ; RADFORD DJ; ADU D; MCGRATH M; SAVAGE COS
    IL-1-BETA PRODUCTION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES STIMULATEDBY ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES - RELEVANCE TO SYSTEMIC VASCULITIS
    Clinical and experimental immunology
    
    C.J. Brooks et al., "IL-1-BETA PRODUCTION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES STIMULATEDBY ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES - RELEVANCE TO SYSTEMIC VASCULITIS", Clinical and experimental immunology, 106(2), 1996, pp. 273-279
41. LOCKWOOD CM
    NEW TREATMENT STRATEGIES FOR SYSTEMIC VASCULITIS - THE ROLE OF INTRAVENOUS IMMUNE GLOBULIN THERAPY
    Clinical and experimental immunology
    
    C.M. Lockwood, "NEW TREATMENT STRATEGIES FOR SYSTEMIC VASCULITIS - THE ROLE OF INTRAVENOUS IMMUNE GLOBULIN THERAPY", Clinical and experimental immunology, 104, 1996, pp. 77-82
42. STEGEMAN CA; TERVAERT JWC; VANSON WJ; TEGZESS AM
    NECROTIZING GLOMERULONEPHRITIS ASSOCIATED WITH ANTIMYELOPEROXIDASE ANTIBODIES IN A RENAL-TRANSPLANT RECIPIENT WITH RENAL-FAILURE OF UNKNOWNORIGIN
    Nephrology, dialysis, transplantation
    
    C.A. Stegeman et al., "NECROTIZING GLOMERULONEPHRITIS ASSOCIATED WITH ANTIMYELOPEROXIDASE ANTIBODIES IN A RENAL-TRANSPLANT RECIPIENT WITH RENAL-FAILURE OF UNKNOWNORIGIN", Nephrology, dialysis, transplantation, 9(7), 1994, pp. 839-842
43. LOCKWOOD CM
    APPROACHES TO SPECIFIC IMMUNOTHERAPY FOR SYSTEMIC VASCULITIS
    Seminars in neurology
    
    C.M. Lockwood, "APPROACHES TO SPECIFIC IMMUNOTHERAPY FOR SYSTEMIC VASCULITIS", Seminars in neurology, 14(4), 1994, pp. 387-392
44. CAMBRIDGE G; WALLACE H; BERNSTEIN RM; LEAKER B
    AUTOANTIBODIES TO MYELOPEROXIDASE IN IDIOPATHIC AND DRUG-INDUCED SYSTEMIC LUPUS-ERYTHEMATOSUS AND VASCULITIS
    British journal of rheumatology
    
    G. Cambridge et al., "AUTOANTIBODIES TO MYELOPEROXIDASE IN IDIOPATHIC AND DRUG-INDUCED SYSTEMIC LUPUS-ERYTHEMATOSUS AND VASCULITIS", British journal of rheumatology, 33(2), 1994, pp. 109-114
45. LI PKT; LEUNG JCK; LAI FM; WANG A; LUI SF; LEUNG CB; LAI KN
    USE OF ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES IN DIAGNOSING VASCULITIS IN A CHINESE PATIENT POPULATION
    American journal of nephrology
    
    P.K.T. Li et al., "USE OF ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES IN DIAGNOSING VASCULITIS IN A CHINESE PATIENT POPULATION", American journal of nephrology, 14(2), 1994, pp. 99-105
46. AUDRAIN MAP; BARANGER TAR; LOCKWOOD CM; ESNAULT VLM
    HIGH IMMUNOREACTIVITY OF LACTOFERRIN CONTAMINATING COMMERCIALLY PURIFIED MYELOPEROXIDASE
    Journal of immunological methods
    
    M.A.P. Audrain et al., "HIGH IMMUNOREACTIVITY OF LACTOFERRIN CONTAMINATING COMMERCIALLY PURIFIED MYELOPEROXIDASE", Journal of immunological methods, 176(1), 1994, pp. 23-31
47. RONDA N; ESNAULT VLM; LAYWARD L; SEPE V; ALLEN A; FEEHALLY J; LOCKWOOD CM
    ANTINEUTROPHIL CYTOPLASM ANTIBODIES (ANCA) OF IGA ISOTYPE IN ADULT HENOCH-SCHONLEIN PURPURA
    Clinical and experimental immunology
    
    N. Ronda et al., "ANTINEUTROPHIL CYTOPLASM ANTIBODIES (ANCA) OF IGA ISOTYPE IN ADULT HENOCH-SCHONLEIN PURPURA", Clinical and experimental immunology, 95(1), 1994, pp. 49-55
48. BOSCH X; LOPEZSOTO A; MIRAPEIX E; FONT J; INGELMO M; URBANOMARQUEZ A
    ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED ALVEOLAR CAPILLARITIS IN PATIENTS PRESENTING WITH PULMONARY HEMORRHAGE
    Archives of pathology and laboratory medicine
    
    X. Bosch et al., "ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED ALVEOLAR CAPILLARITIS IN PATIENTS PRESENTING WITH PULMONARY HEMORRHAGE", Archives of pathology and laboratory medicine, 118(5), 1994, pp. 517-522
49. KALLENBERG CGM
    AUTOANTIBODIES IN VASCULITIS - CURRENT PERSPECTIVES
    Clinical and experimental rheumatology
    
    C.G.M. Kallenberg, "AUTOANTIBODIES IN VASCULITIS - CURRENT PERSPECTIVES", Clinical and experimental rheumatology, 11(4), 1993, pp. 355-360
50. ARIMURA Y; MINOSHIMA S; KAMIYA Y; TANAKA U; NAKABAYASHI K; KITAMOTO K; NAGASAWA T; SASAKI T; SUZUKI K
    SERUM MYELOPEROXIDASE AND SERUM CYTOKINES IN ANTIMYELOPEROXIDASE ANTIBODY-ASSOCIATED GLOMERULONEPHRITIS
    Clinical nephrology
    
    Y. Arimura et al., "SERUM MYELOPEROXIDASE AND SERUM CYTOKINES IN ANTIMYELOPEROXIDASE ANTIBODY-ASSOCIATED GLOMERULONEPHRITIS", Clinical nephrology, 40(5), 1993, pp. 256-264
51. WARNY M; BRENARD R; CORNU C; TOMASI JP; GEUBEL AP
    ANTINEUTROPHIL ANTIBODIES IN CHRONIC HEPATITIS AND THE EFFECT OF ALPHA-INTERFERON THERAPY
    Journal of hepatology
    
    M. Warny et al., "ANTINEUTROPHIL ANTIBODIES IN CHRONIC HEPATITIS AND THE EFFECT OF ALPHA-INTERFERON THERAPY", Journal of hepatology, 17(3), 1993, pp. 294-300
52. SOLER C; DUPREGOUDABLE C; REY JP; MODESTO A; OKSMAN F; SUC JM
    ANTINEUTROPHIL CYTOPLASM AUTOANTIBODIES - SPECIFICITY IN RENAL VASCULITIS
    Annales de biologie clinique
    
    C. Soler et al., "ANTINEUTROPHIL CYTOPLASM AUTOANTIBODIES - SPECIFICITY IN RENAL VASCULITIS", Annales de biologie clinique, 51(2), 1993, pp. 133-139